Plaintiffs Seek Discovery Concerning Pfizer's Interactions with Physicians

SAN FRANCISCO - Plaintiffs in the federal Bextra/Celebrex MDL have asserted that Pfizer Inc. and other defendants must produce documents concerning the companies' interactions with plaintiffs' treating physicians, stating that plaintiffs are entitled to know what information influenced doctors' opinions on the drugs. In Re: Bextra and Celebrex Marketing, Sales Practices and Product Liability Litigation, MDL No. 1699 (N.D. Calif.).

In an April 10 motion, plaintiffs in four cases in the U.S. District Court for the Northern District of California seek an order requiring the Pfizer defendants to fully respond to plaintiffs' requests for call notes, payment and/or honorarium histories, …